Back to search

Institutional Repository of Vilnius University

Biomimetinių lipidinių nanodalelių CRISPR-Cas9 įkapsuliavimui formavimas ir optimizavimas /

Abstract

dc:description

The discovery of the CRISPR/Cas9 system revolutionized genetic engineering and opened new doors to gene therapy. However, effective delivery of this system into human cells remains a challenge. To address this, lipid nanoparticles (LNPs) can be employed. So far, approved gene therapy drugs are based on mRNA or siRNA, but the Cas9_sgRNR RNP complex offers faster and more precise action. Due to its large molecular weight and negative charge, the Cas9_sgRNR complex is difficult to deliver. For this purpose, cationic and ionizable lipids are used. In this study, LNPs containing the cationic lipid DOTAP and the ionizable lipid ALC 0315 were developed and optimized. The initial step of the study focused on evaluating the stability of four different lipid compositions over seven days. The most stable formulation was LND_1 = DOPC/DOPE/chol/DOTAP/DMG-PEG 30/15/30/20/5 (mol/mol). Next, the optimal size of the LNPs was determined based on the polydispersity index (PdI) and the encapsulation efficiency of BSA Alexa Fluor 488. LNPs formed using a membrane with 200 nm pores (d = 183 nm) were selected, showing an encapsulation efficiency of 74% for BSA Alexa Fluor 488. When encapsulating the Cas9-GFP_sgRNR complex, the efficiency was 57%. Following this, LNP_5 particles containing the ionizable lipid ALC 0315 were formed. Compared to LND_1, these had a smaller diameter (d = 126 nm), but the encapsulation efficiencies for BSA Alexa Fluor 488 and Cas9-GFP_sgRNR differed only slightly. Subsequent experiments aimed to examine the effect of gastrointestinal tract-mimicking media on both LNP compositions. The results showed that after exposure to gastrointestinal environments, the PdI of the LNPs increased significantly. Nonetheless, the protein remained protected from degradation in synthetic saliva solution and was partially protected in synthetic gastric fluid. In the small intestine-mimicking medium, where the LNPs showed the highest PdI, the fluorescence of BSA Alexa Fluor 488 was no longer detectable—indicating that the protein was degraded and the LNPs were disrupted.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bužinskytė, Kamilė,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bužinskytė, Kamilė,. Biomimetinių lipidinių nanodalelių CRISPR-Cas9 įkapsuliavimui formavimas ir optimizavimas /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD239020796&prefLang=en_US